[1] |
Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng.
Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273.
|
[2] |
Huang Misun, Wu Yaning, Li Guilian, Liu Haican.
Research advances of Mycobacterium tuberculosis enrichment technology
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373.
|
[3] |
Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan.
Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180.
|
[4] |
Expert Consensus on the Diagnosis and Treatment of Spinal Tuberculosis Combined with HIV/AIDS Patients Group, Combined with HIV/AIDS Patients Group Chinese Antituberculosis Association, Chinese Antituberculosis Association of STD and AIDS Prevention and Control, the Western China Bone Tuberculosis Alliance, the North China Bone the North China Bone.
Expert consensus on diagnosis and treatment of spinal tuberculosis with HIV/AIDS (2nd Edition)
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 1-11.
|
[5] |
Zhang Guoqin, Qu Ting, Meng Qinglin, Zhou Lin, Liu Eryong.
Implementation update of strategy for the control of tuberculosis and HIV/AIDS co-infection in China
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 12-17.
|
[6] |
Li Fudong, Ma Xiaoxue, Zhou Jian, Wang Dafu, Zhang Yueying, Gong Tingting, Rao Wen, Hong Feng, Li Shijun, Li Jinlan.
Characteristics and treatment outcome analysis of MTB/HIV dual infection patients in Guizhou Province from 2018 to 2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 36-43.
|
[7] |
Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei.
Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60.
|
[8] |
Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei.
Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
|
[9] |
Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei.
Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097.
|
[10] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
[11] |
Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping.
Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 648-653.
|
[12] |
Liu Meijun, Li Feng.
Current situation and research progress of co-infection of HIV/AIDS and subclinical tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 596-600.
|
[13] |
Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin.
Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423.
|
[14] |
Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan.
Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020
[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339.
|
[15] |
Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan.
An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334.
|